Stocks in Focus: Omeros Corporation (NASDAQ:OMER), Rare Element Resources Ltd (NYSEMKT:REE)
Northern, WI 05/10/2013 (GDPInsider) – Omeros Corporation (NASDAQ:OMER) is rallying in today’s trading and is up 9.70%. The stock opened at 4.22, 0.05 above its previous close of 4.17 and has a range of 4.16 and 4.75. The stock has a 52-week range of 3.65 and 13.45 and at present trading levels, OMER is up 23.56% on its 52-week low and down 66.47% on its 52-week high. Analysts have set a target price of 16.14 for the stock and EPS Q/Q has risen 34.46%.
The company recently announced its agreement to sell 3,903,004 shares of its common stock at a price of $4.14 per share. Omeros expects to earn around $16.1 million from the offering once it closes on are near May 14, 2013. Management has indicated that the funds will be used to bolster efforts for the commercialization of OMS302, the companies intended offering for intraocular lens replacement.
OMER is trading 0.26 above its SMA50 and 13.06% above its SMA20. The stock has a RSI of 59.18, indicating that at present trading levels the stock is neither oversold nor overbought.
Is OMER a solid investment at these levels? Get exclusive data and trends here.
Rare Element Resources Ltd (NYSEMKT:REE) is up 14.84% after starting today’s trading session at 1.84. The stock had closed previously at 1.82 and has a volume of 937.24K—more than three times its average volume of 253.69K.
Rare Element Resources has a market cap of $91.70 million and recently filed its Q1 2013 earnings results. CEO Randall Scott was very upbeat about the direction the company was taking and indicated that Q1 2013 was positive on several fronts. “The first quarter of 2013 is marked by some major milestones. During the first quarter, we not only substantially expanded the Measured and Indicated (M&I) resource at the Bear Lodge Critical Rare Earth Project but also identified the first-ever Indicated resource at the heavy rare earth-enriched (HREE) Whitetail deposit,” remarked Scott at the earnings briefing.
REE is trading 3.03% below its SMA50 and 10.78% above its SMA20. The stock has a healthy RSI of 56.37 indicating that there’s room for investors to capitalize on future gains. Analysts have set a target price of 6.05 for REE and the stock is up 26.87% on its 52-week low of 1.60.
How Should Investors Trade REE Now? Get exclusive insights and updates here.
WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.